SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056516
Filing Date
2021-11-12
Accepted
2021-11-12 08:41:32
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 Q3'21 10-Q alxo-10q_20210930.htm   iXBRL 10-Q 3056530
2 EX-31.1 alxo-ex311_9.htm EX-31.1 21058
3 EX-31.2 alxo-ex312_6.htm EX-31.2 20963
4 EX-32.1 alxo-ex321_8.htm EX-32.1 9465
5 EX-32.2 alxo-ex322_7.htm EX-32.2 9552
  Complete submission text file 0001564590-21-056516.txt   8218614

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alxo-20210930.xsd EX-101.SCH 53980
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxo-20210930_cal.xml EX-101.CAL 52449
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxo-20210930_def.xml EX-101.DEF 162031
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20210930_lab.xml EX-101.LAB 408963
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20210930_pre.xml EX-101.PRE 290429
11 EXTRACTED XBRL INSTANCE DOCUMENT alxo-10q_20210930_htm.xml XML 1162514
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 211400049
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences